Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,048 hedge funds and large institutions have $44.5B invested in Allergan plc in 2017 Q4 according to their latest regulatory filings, with 168 funds opening new positions, 313 increasing their positions, 479 reducing their positions, and 200 closing their positions.
4% less funds holding
Funds holding: 1,090 → 1,048 (-42)
16% less first-time investments, than exits
New positions opened: 168 | Existing positions closed: 200
18% less funds holding in top 10
Funds holding in top 10: 49 → 40 (-9)
21% less capital invested
Capital invested by funds: $56B → $44.5B (-$11.5B)
34% less call options, than puts
Call options by funds: $1.32B | Put options by funds: $2B
35% less repeat investments, than reductions
Existing positions increased: 313 | Existing positions reduced: 479
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Southeastern Asset Management
Memphis,
Tennessee
|
+$412M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$337M |
| 3 |
AL
Appaloosa LP
Short Hills,
New Jersey
|
+$283M |
| 4 |
BG
Baupost Group
Boston,
Massachusetts
|
+$276M |
| 5 |
GCM
Glenview Capital Management
New York
|
+$207M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$699M |
| 2 |
Jennison Associates
New York
|
-$387M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$267M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$244M |
| 5 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$206M |
AGN Hedge Fund Activity: Q4 2017 in Review
1,048 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q4 2017, worth a combined $44.5B — down 21% from $56B a quarter earlier.
Sellers outnumbered buyers: 200 funds closed out of AGN and 168 opened new positions — a net loss of 32 holders — while 479 trimmed existing stakes and 313 added.
The largest buyer was Southeastern Asset Management, opening a new position worth an estimated $412M. The largest seller was Fidelity Investments, cutting an estimated $699M.
- 1,048 institutional investors held Allergan plc (AGN) as of Q4 2017, down from 1,090 in Q3 2017.
- Funds reported $44.5B of Allergan plc stock for Q4 2017, down 21% quarter-over-quarter.
- 168 funds opened new Allergan plc positions in Q4 2017 and 200 closed out, a net change of -32 holders.
- The largest Allergan plc buyer in Q4 2017 was Southeastern Asset Management, an estimated $412M added.
- The largest Allergan plc seller in Q4 2017 was Fidelity Investments, an estimated $699M sold.
Based on aggregated 13F filings for Q4 2017.